Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Natroba Topical Suspension 0.9% 120 Ml By Prapro Llc

Image 0 of Natroba Topical Suspension 0.9% 120 Ml By Prapro LlcImage 1 of Natroba Topical Suspension 0.9% 120 Ml By Prapro Llc

Natroba Topical Suspension 0.9% 120 Ml By Prapro Llc

Call for Price

Natroba Topical Suspension 0.9% 120 Ml By Prapro Llc This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD4376588/RXB10091994
Size : 120 ML
Selling UoM : EA
NDC: 52246-0929-04
UPC Barcode : 352246929042
Supplier: 0050003368 PARAPRO LLC
Supplier Material : 092904
Generic Code : 066988 SPINOSAD TOPICAL SUSPENSION 0.9 %
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : BRX Branded RX

Have a question?

  Call for Price

Product Description.:

Suspension , peach
ViscousSlightly opaque

*In clinical studies Natroba Topical Suspension has been shown to be effective in eliminating head lice infestations in most patients with a single treatment. If live lice are seen one week (7 days) after the first application, Natroba Topical Suspension should be used again. A fine-tooth comb may be used to remove dead lice and nits from the hair and scalp, but combing is not required. For more information about Natroba Topical Suspension, talk with your doctor and see the Important Safety Information below.

--------------------------------------------------------------------------------

Ask your doctor if Natroba Topical Suspension is right for you or your child.

INDICATION
Natroba Topical Suspension is a pediculicide indicated for the topical treatment of head lice infestations in patients four (4) years of age and older.
IMPORTANT SAFETY INFORMATION
Natroba Topical Suspension contains benzyl alcohol and is not recommended for use in neonates and infants below the age of 6 months. Systemic exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants.
Most common adverse events were: application site redness (3%), redness and irritation of the eyes (2%) and application site irritation (1%).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.